Skip to main content
Top
Published in: World Journal of Surgery 10/2010

01-10-2010

Increased Hepcidin Production Impairs Iron Metabolism after Pancreatoduodenectomy

Authors: Takayuki Kosuge, Tokihiko Sawada, Mitsugi Shimoda, Junji Kita, Naohisa Tomosugi, Keiichi Kubota

Published in: World Journal of Surgery | Issue 10/2010

Login to get access

Abstract

Background

The duodenum is a central organ for iron absorption. This study was performed to evaluate changes in body iron concentration and other iron-related molecules sequentially, in patients undergoing pancreatoduodenectomy (PD).

Methods

Twenty-one patients who had undergone PD at our department were enrolled in the study. Measurements of serum iron (sFe), total iron-binding capacity (TIBC), serum ferritin (sFer), C-reactive protein (CRP), interleukin-6 (IL-6), hemoglobin (Hb), hematocrit (Ht), and serum hepcidin (sHep) were performed before surgery (Pre), and on postoperative days 3 (D3), 7 (D7), and 14 (D14).

Results

The median values of sFe on Pre, D3, D7, and D14 were 73.0, 30.0, 33.0, and 41.0 μg/ dL, respectively (P < 0.05), and those of TIBC were 276.0, 160.0, 176.0, and 165.0 μg/ dL, respectively (P < 0.05). CRP and IL-6 became maximal on D3. The median values of sHep on Pre, D3, D7, and D14 were 18.9, 42.9, 25.7, and 21.2 mg/dL, respectively (P < 0.05). Hb and Ht reached minimum values on D3 and remained low until D14. The median values of sFer on Pre, D3, D7, and D14 were 135, 301, 267, and 233 ng/ dL, respectively.

Conclusions

Hepcidin production is increased after pancreatoduodenectomy. Because hepcidin is known to divert iron to storage-type ferritin rather than to erythropoiesis, iron administration intended for erythropoiesis during this period may be ineffective.
Literature
1.
go back to reference McKie AT, Barrow D, Latunde-Dada GO et al (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291:1755–1759CrossRefPubMed McKie AT, Barrow D, Latunde-Dada GO et al (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291:1755–1759CrossRefPubMed
2.
go back to reference Gunshin H, Mackenzie B, Berger UV et al (1997) Cloning and characterization of a mammalian proton-coupled metal-iron transporter. Nature 388:482–488CrossRefPubMed Gunshin H, Mackenzie B, Berger UV et al (1997) Cloning and characterization of a mammalian proton-coupled metal-iron transporter. Nature 388:482–488CrossRefPubMed
3.
go back to reference Donovan A, Brownlie A, Zhaou Y et al (2000) Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403:776–781CrossRefPubMed Donovan A, Brownlie A, Zhaou Y et al (2000) Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403:776–781CrossRefPubMed
4.
go back to reference Kubota K, Makuuchi M, Takayama T et al (2000) Appraisal of two-staged pancreatoduodenectomy: its technical aspects and outcome. Hepatogastroenterology 47:269–274PubMed Kubota K, Makuuchi M, Takayama T et al (2000) Appraisal of two-staged pancreatoduodenectomy: its technical aspects and outcome. Hepatogastroenterology 47:269–274PubMed
5.
go back to reference Iqbal N, Lovegrove RE, Tilney HS et al (2008) A comparison of pancreaticoduodenectomy with pylorus preserving pancreaticoduodenectomy: a meta-analysis of 2822 patients. Euro J Surg Oncol 34:1237–1245 Iqbal N, Lovegrove RE, Tilney HS et al (2008) A comparison of pancreaticoduodenectomy with pylorus preserving pancreaticoduodenectomy: a meta-analysis of 2822 patients. Euro J Surg Oncol 34:1237–1245
6.
go back to reference Yeo CJ, Cameron JL, Sohn TA et al (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–260CrossRefPubMed Yeo CJ, Cameron JL, Sohn TA et al (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–260CrossRefPubMed
7.
go back to reference Sugarman HJ, Londry GL, Kellum JM et al (1989) Weight loss with vertical banded gastroplasty and Roux-en-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 157:93–102CrossRef Sugarman HJ, Londry GL, Kellum JM et al (1989) Weight loss with vertical banded gastroplasty and Roux-en-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 157:93–102CrossRef
8.
go back to reference Rabkin RA, Rabkin JM, Metacalf B et al (2004) Nutritional markers following duodenal switch for morbid obesity. Obes Surg 14:84–90CrossRefPubMed Rabkin RA, Rabkin JM, Metacalf B et al (2004) Nutritional markers following duodenal switch for morbid obesity. Obes Surg 14:84–90CrossRefPubMed
9.
go back to reference Park CH, Valore EV, Warinq AJ et al (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810CrossRefPubMed Park CH, Valore EV, Warinq AJ et al (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810CrossRefPubMed
10.
go back to reference Kijima H, Sawada T, Tomosugi N et al (2008) Expression of hepcidin-mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer 8:167CrossRefPubMed Kijima H, Sawada T, Tomosugi N et al (2008) Expression of hepcidin-mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer 8:167CrossRefPubMed
11.
go back to reference Nemeth E, Valore EV, Territo M et al (2005) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood 106:2196–2199CrossRefPubMed Nemeth E, Valore EV, Territo M et al (2005) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood 106:2196–2199CrossRefPubMed
12.
go back to reference Kobune M, kohgo Y, Kato J et al (1994) Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rat. Hepatology 19:1468–1475CrossRefPubMed Kobune M, kohgo Y, Kato J et al (1994) Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rat. Hepatology 19:1468–1475CrossRefPubMed
13.
go back to reference Eleftheriadis T, Liakopoulos V, Antoniadi G et al (2009) The role of hepcidin in iron homeostasis and anemia in hemodialysis patients. Semin Dial 22:70–77CrossRefPubMed Eleftheriadis T, Liakopoulos V, Antoniadi G et al (2009) The role of hepcidin in iron homeostasis and anemia in hemodialysis patients. Semin Dial 22:70–77CrossRefPubMed
14.
go back to reference Fleming MD (2008) The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematol Am Soc Hematol Educ Program 151–158 Fleming MD (2008) The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematol Am Soc Hematol Educ Program 151–158
Metadata
Title
Increased Hepcidin Production Impairs Iron Metabolism after Pancreatoduodenectomy
Authors
Takayuki Kosuge
Tokihiko Sawada
Mitsugi Shimoda
Junji Kita
Naohisa Tomosugi
Keiichi Kubota
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 10/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0657-3

Other articles of this Issue 10/2010

World Journal of Surgery 10/2010 Go to the issue